Skip to main content
. 2022 Jul 20;23(4):547–559. doi: 10.1007/s40257-022-00702-2
Download video file (211.9MB, mp4)

Video abstract: What is the impact of tralokinumab plus topical corticosteroids in adults with moderate-to-severe atopic dermatitis over 32 weeks? (MP4 216,988 KB)